Background illustration for clinical trials search

Multiple Myeloma Clinical Trials

Browse 1,243 multiple myeloma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion

for
Multiple Myeloma
Location: Seattle WA
Sponsor: Swedish Medical Center

Sex: All

Age: 18 - 70

Code: NCT03570983

Phase2, Recruiting

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

for
Multiple Myeloma
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT03127761

Recruiting

Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry

for
Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 50+

Code: NCT05556928

Recruiting

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

for
High-risk Smoldering Multiple Myeloma,
Location: Boston MA, Denver CO, Portland OR
Sponsor: Irene Ghobrial, MD

Sex: All

Age: 18+

Code: NCT05469893

Phase2, Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed and/or Refractory Multiple Myeloma
Location: Boston MA, New Haven CT, New York NY, Tampa FL,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06153251

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL, Salt Lake City UT
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18+

Code: NCT05344833

Phase2, Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

for
Leukemia, Lymphoma, Multiple Myeloma, Blood Cancer,
Location: Calgary
Sponsor: Alberta Health Services, Calgary

Sex: All

Age: 18+

Code: NCT05190653

Recruiting

Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma

for
Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT06185751

Phase1, Recruiting

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

for
Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL,
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal

Sex: All

Age: 18 - 65

Code: NCT03091933

Phase1, Phase2, Recruiting

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

for
Multiple Myeloma
Location: Boston MA, New York NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05137054

Phase1, Recruiting

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

for
Multiple Myeloma, Lymphoma
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT05135351

Recruiting

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06105554

Phase1, Phase2, Recruiting

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency

for
Multiple Myeloma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT04240054

Phase2, Recruiting

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06106945

Phase1, Phase2, Recruiting

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

for
Multiple Myeloma
Location: Canton OH
Sponsor: Starton Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06087653

Phase1, Phase2, Recruiting

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, Hackensack NJ, Baltimore MD,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05372354

Phase1, Phase2, Recruiting

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06622005

Phase1, Recruiting

Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

for
Relapsed Multiple Myeloma, Refractory Multiple Myeloma
Location: Boston MA, Rochester NY, Chapel Hill NC, Detroit MI,
Sponsor: Opna Bio LLC

Sex: All

Age: 18+

Code: NCT06433947

Phase1, Recruiting

Hypofractionation (Radiation) Trial for Multiple Myeloma

for
Multiple Myeloma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06270888

Phase1, Recruiting

Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab

for
Multiple Myeloma, Refractory Multiple Myeloma
Location: Seattle WA
Sponsor: Pack Health

Sex: All

Age: 18+

Code: NCT05053607

Recruiting